Orchid Pharma Limited (ORCHPHARMA) — Financial Results

· NSE Neutral
📢 Key Event
Trading window closure announced for Q1 FY2026-27 results
💡 Investor Takeaway
Trading is prohibited during the specified window to ensure compliance with insider trading rules.

Orchid Pharma announced that its trading window will close on July 1, 2026, ahead of the unaudited limited reviewed financial results for Q1 FY2026-27 ending June 30, 2026, as required by SEBI insider trading regulations.

📄 View Original Announcement (PDF)

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day